ĐĎॹá>ţ˙ ţ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙ý˙˙˙ţ˙˙˙ţ˙˙˙ţ˙˙˙  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGţ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙Root Entry˙˙˙˙˙˙˙˙FBw0lžp€ä-Ž-Ĺ€CompObj˙˙˙˙˙˙˙˙˙˙˙˙nPowersimDocument"˙˙˙˙˙˙˙˙ †˙˙˙˙˙˙˙˙˙˙˙˙ţ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙ţ˙ ˙˙˙˙FBw0lžpPowersim 2 DiagramPowersimDiagramPowersim.Diagram.2ô9˛qFORM†SIM VER Z“NMDIDkăŁKuJ…Šő]xł‰FSPW'FORM…ĆWSMDFORMINFOETYPTITLValue Depletion Model #6AUTH Bill BraunSUMIDChange from #6: Change COGSPerUnit and PriceAtPOS to auxiliaries.CRT1U0LSTMU0LSBY8)ĄčšfîŢ5a˙ëç o:8Vşzœz޸tŔËÚůƒ…a@ÝŽ›1-iž{÷6P™Ú-ŃARPW'ACSRFORM|RUN FORM6LIB LNM PSXFSTD.DLLUSED€J€€€S€€€.€5€€€STATMAGIoSOP FORM,RSTPRCNTRDELATPS đ?UNAM—YearUDSCCaldendar YearTMUTRDNM—RENM—RDDFVNAM›—tBFutureHarmIndexInitProductPrice5KChangeInFutureHarmYearsOfEvidenceDelayProductHarmPotentialChangeInProductDesignRandDBudgetAppliedRandDImpactDelay NetIncome Population$D FHPoolBalanceRetainedEarnings IllnessBurden ProductDemandPVFHCostPerProductFHPoolInterestProductionOverheadOlProducerPmtsToFHPool CostOfRealHarmIncurred PurchaserPmtsToFHPool InitProductPriceStock7MCOGSPerProduct 'Labor ( Materials ) ActualMarginGbCHangeInIllnessBurden1ProductAttractiveness.ProductAwarenessLag/ChangeInProductDemand0FutureHarmImpactDelay2AnnualRandDBudgetJkProductPriceAtPOS;PercentChxInProductPrice7L TargetMargin= TotalFHCost7NInflows!AOutflows!BNIToRE!CProducerSharePVFHCostGd DxFrequency;UInitFHCostYearFactor$GOnsetOfTxDelay$H DxOccurences$IPurchaserSharePVFHCostGe cumminflows=Z TxCostPerDx7PPVRate<XNetProducerPmtsToFHPool<WFHCostPerProduct;VFHCost7TFHCostFOrecastŽpPVFHCost’sActualMarginPercentChangeGcProductsPerPersonPerYear=^AvgProductsPerPersonPerDay=_ProductsProduced=`VSWC8##'##'#########'#'''#####'##'######'''###########'######VFTP8VTYP8VUNTWFraction Dollars/UnitFractionYearsFractionFraction Dollars/YearYears Dollars/YearPersons Dollars/UnitDollarsFractionFraction Dollars/UnitDollars Dollars/Unit Dollars/Unit Dollars/Year Dollars/Unit Dollars/Unit Dollars/Unit Dollars/Unit Dollars/Unit Dollars/UnitFractionFractionYearsFractionYears Dollars/Year Dollars/UnitFraction Dollars/UnitDollars Dollars/Year Dollars/Year Dollars/Year Dollars/Unit Frequency DimensionlessYearsDx/Year Dollars/Unit Dollars/Year Dollars/DxFraction Dollars/Year Dollars/Unit Dollars/YearFractionUnits/Person/YearUnits/Person/Day Units/YearNUM @đ?@đ? đ?jř@¸…ëQ¸Ž?š™™™™™É?ŽGázŢ? ףp= ç?…ëQ¸…ë?ffffffî? ףp= ď?đ?$@@ˆĂ@đ?đ?đ?đ?Đ?đ?đ?ŕ? Đ?š™™™™™Š?š™™™™™ő?333333ó?š™™™™™ń?ÍĚĚĚĚĚđ?ffffffđ?đ?333333ď?ffffffî?ÍĚĚĚĚĚě?š™™™™™é?ÍĚĚĚĚĚä?@$@đ?ŕ?Y@Ăő(\B@N@@@@@ŕ?ˆă@š™™™™™Š?@4@4@đ?đ?€v@@DEF P $$6€$,€$$€$€   $  # 5€€$€$ € $( .€       $<$3€      $9€$4€€$;€ $ $9€  $1$B€'<$4 # S€ $6$B€$$$€$1€$€   $$€ $$€$&€"$+ € # 5€# $$#$€$$€% & ($$6€$,€*$*$€$*€+ , - $*$B€.$$B€$€$€/$ 0 $ €1 2 3 4$ €$@ €€$2€$€5 $ €6$$€$€7 8 9 :$<$B€ .€; $5$8€ €<$<  J€= $9€$4€€$<€>$,$ €$,€? $A€$€@ A $ $@€BFDEFŇ$€$€$.€$/€$0€$€ $€$€$€$€ $0€ $"€$%€$<€-$€:VDIMVDP1Śv2Z&"MqRfn2fF‚ RZ‚  z~FRbv:.BZv2b*‚ *V‚ v*J:.J‚JNV^r‚ bVrrfR2‚B.‚CSEQ98498 2A@5?VOFS8    !"#$%&'()*+,-./0 1234567SIZE 8FORMžSCTXSCNTFORMˆSCE TIMS)^@đ?{ŽGáz„?{ŽGáz„?RSLTSCL @ŽGázŽď?)\Âő(đ?5K@Âő(\Â@đżđ?ÍĚĚĚĚĚ@433333@ŽGázŽď?)\Âő(đ?đżđ?đżđ?  ÍĚĚĚĚĚ@433333@ űdA $DVĂ@şĂ@ €“ܤA€PŢŠA ű„AŽGázŽď?)\Âő(đ?ŽGázŽď?)\Âő(đ?)\Âő(Ě? ˜`ADĘdAOlŽGázŽĎ?)\Âő(Đ? €O2A đłJA €O2A7M-˛ď§Ć@ÓMbX9@ 'ü?Ăő(\Âý? (ŽGázŽď?)\Âő(đ? )ŽGázŽß?)\Âő(ŕ? Gb{ŽGázě?đ?"1đżđ?#.7‰A`ĺĐî?đ?$/ŽGázŽ˙?)\Âő(@%0Üů~jźt“ż&2ÍĚĚĚĚĚ#@333333$@(Jkđżđ?*;@Âő(\Â@+7LäĽ›Ä °˛?,=ŽGázŽď?)\Âő(đ?-7NŢ9ŞA.!AúR|Aęœ~A/!Bß×qAĽ4rA0!CűdA1Gd)\Âő(ź?2;UŔX@@Y@3$Gjźt“@•C‹l@4$H33333łM@ÍĚĚĚĚLN@5$I´@ ‘@6Ge)\Âő(ź?7=Z ˜`AP-iA87PVă@şă@9<XňŇMbXŠ?B`ĺĐ"ŰŠ?:<Wđżđ?;;V@<7Tşc„A&τA=Žpşc„A&τA>’s´vAA€ŇAA?Gc)\Âő(ź?@=^´@ ‘@A=_—nƒŔ@> ףp=@B=`şcdA&ĎdAFORM1ęRCDTRCE Š‚c€EValue Depletion Model #7 Individual Product View v03.15.2005, 16.10=˙ 0Arial˙˙˙˙˙S%RCE v‚cEndogenous Dynamics=˙ 0Arial˙˙˙˙˙S%RCE u‚cExogenous Dynamics=˙ 0Arial˙˙˙˙˙S%RCE ’‚ţc/Miscellaneous Equations for Behavior Assessment=˙ 0Arial˙˙˙˙˙S%RCE i‚ žcOutput=˙ 0Arial˙˙˙˙˙S%RCE  ˛ łc˙˙˙˙˙˙˙˙˙˙Product DemandL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE  ś ¸<c˙˙˙˙˙˙˙˙˙˙Future Harm CostL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE  ť ˝Bc˙˙˙˙˙˙˙˙˙˙Products ProducedL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE   Ŕ  c˙˙˙˙˙˙˙˙˙˙Future Harm Pool BalanceL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE Ę Ů Ú7 Űc˙˙˙˙˙˙˙˙˙˙&Future Harm Pool Inflows vs. OutflowsL˙ ź"ArialNew Roman˙˙˙˙˙[˙0Arial˙˙˙˙˙[˙"Arial[˙"Arial {TimeUnit}‡@‡@ŽFH Pool Inflows‹ FH Harm Incurred‹ {Par}UYRCE g Ţ ŕ á7c˙˙˙˙˙˙˙˙˙˙.Future Harm Pool Inflows (1) vs. Outflows (2)L˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE Ł ä ć č éc˙˙˙˙˙˙˙˙˙˙9Product Harm Potential, Future Harm Index, Illness BurdenL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE  î ňc˙˙˙˙˙˙˙˙˙˙ COGS per UnitL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE Ö ů ú(c˙˙˙˙˙˙˙˙˙˙{par}=˙ 0Arial˙˙˙˙˙=˙ 0Arial gpRCE  ˙ #c˙˙˙˙˙˙˙˙˙˙Product AttractivenessL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE U   < =c˙˙˙˙˙˙˙˙˙˙Future Harm Cost w\ ForecastL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE ‰ ’ • c˙˙˙˙˙˙˙˙˙˙Future Harm PoolL˙ ź"ArialNew Roman˙˙˙˙˙[˙0Arial˙˙˙˙˙[˙"Arial[˙"Arial {TimeUnit}‡@‡@‹ {Par}‹ {Par}UYRCE " Ş Źc˙˙˙˙˙˙˙˙˙˙Cost of Real Harm IncurredL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE QÍĐ,Ň c˙˙˙˙˙˙˙˙˙˙Target vs. Actual MarginL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE )>c˙˙˙˙˙˙˙˙˙˙!Present Value of Future Harm CostL˙ ź"ArialNew Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE \^ c˙˙˙˙˙˙˙˙˙˙ăţ0Times New Roman˙˙˙˙˙ {TIMEUNIT}=˙ 0Arial˙˙˙˙˙[˙0Arial {Par:Global}=˙ „0Arial˙˙˙˙˙[˙0Arial[˙0Arial˙˙˙˙˙[˙0Arial˙˙˙˙˙ ˙˙˙˙˙{Par:Individual} ˙˙˙˙˙{Par:Individual}[˙0ArialA4RCE Öcd(c˙˙˙˙˙˙˙˙˙˙{par}=˙ 0Arial˙˙˙˙˙=˙ 0Arial gpFORMRIDTRIE ‚R5RIE ‚R5RIE ‚R5RIE ‚ţR5RIE ‚ žR5RIE W ˛^@4@$@…ëQ¸…ë?đ?š™™™™™Š?{ŽGáz„?˙ ł˙VxRIE W ś^@4@$@ĐSAű„AĐcA€„.A˙ ¸˙VxRIE W ť^@4@$@0ŒaAp™dA€„Ajř@˙ ˝˙VxRIE W Ŕ^@4@$@Ŕ ZB _ ňAeÍÍA˙ Â˙VxRIE 5 Ů^@4@˙ Ú˙ Ű˙•URIE ] Ţ^@4@$@8œźA„×—AĐsA˙ á˙ ŕ˙VxRIE c ä^@4@$@ěQ¸…ëÁ?đ?433333Ó?š™™™™™™?˙ č˙ é˙ ć˙VxRIE W î^@4@$@ü?R¸…ëQ@š™™™™™Š?{ŽGáz„?˙ ň˙VxRIE  ů˙˙˙˙˙˙˙˙vRIE W ˙^@4@$@333333ë?đ?š™™™™™Š?{ŽGáz„?˙ ˙VxRIE ] ^@4@$@`ăFAű„AĐcA€„>A˙  ˙ ˙VxRIE / ’^@4@˙ •˙•URIE W Ş^@4@$@ˆ*qAĐSA€„.A˙ Ź˙VxRIE ]Í^@4@$@¸…ëQ¸ć?)\Âő(đ?š™™™™™š?{ŽGáz„?˙Đ˙Ň˙VxRIE W^@4@$@€„.AŕýLA€„Ajř@˙˙VxRIE W\^@I@$@`ăfAĐSA€„.A˙^˙VxRIE c˙˙˙˙˙˙˙˙vFORM3˜WSEDFORM3ŒDGEDFORMDGCPVWRDM 4(&$#" +8/.<2bCOPi`fge cs2W &(}J68<C? y0Y[]SDEFě1 €+€6+€,(€-€)/€51^(((1- 5(€C,0,100000,[0,0.06,0.2,0.47,0.72,0.86,0.95,0.97,1"Min:0;Max:1.5"]))-€)/€ ) .(€(,10)5010000€<*€3011(1/((1+€9)^€4))*€;€ *€9.25€1*€B S(€<,€4,1,0)€6*€B€(€+€+€1+€)1.00.5€-€(€-€)/€&V 5(€+M,-0.25,0.05,[1.35,1.2,1.1,1.05,1.025,1,0.975,0.95,0.9,0.8,0.65"Min:0;Max:2"])2(€#-€)/€$100(€+€6+€,)(€*-€)/€*1.000€**€B(€*€B)+€-€€ €*0.51004.06560!(€ /1000)*(€@/1000)*€2*€€*0.5 €+€+€40000.050 .(€</€B,5) (0,€5*€8) J(€< , 20, 20)(1/((1+€9)^€4))*€<(€,-€ )/€, 360*€A*€3€ *€@SDIMSIDXSDOC KSThe current future harm index of the product; actuarial assessment by external body)Initial price of product at point of saleChange in the cost of FHmYears of evidence considered by actuarial body to substantiate the effects of a change in product harm rating,Init value set to 1; net of R&D expenditures‚V„I‚7„Y‚(„u‚ƒ˙ƒ˙ILK !'…J‚…8‚…'‚…‚ƒ˙ ILK $)"nƒJdƒ8Uƒ+9ƒƒ˙ƒ˙CON itƒT ƒ˙ƒ˙ƒ˙NOS AUX ?V„cŽo Uzƒ˙ƒ˙LEV (`‚-ˆWƒ˙k[ƒ˙ƒ˙wNOS LEV % ‚ †9ƒ˙oaƒ˙ƒ˙%LEV ‰Kƒ6 ƒ˙ƒ˙ƒ˙ƒ˙ƒ˙LEV 3%„{‡ L9{;ƒ˙ƒ˙LEV $"ˆYˆkƒ˙"ƒ˙ƒ˙"ƒ˙LEV  &‰J‚ ƒ˙ ;ƒ˙ƒ˙ILK !9…G‚H…=‚-…"‚.…‚ƒ˙(CON X…K‚Tƒ˙'ƒ˙ƒ˙ILK !r{ƒcƒ%Tƒ;ƒƒ˙NOS AUX 8„{‰*5:ƒ˙ƒ˙ILK %zK„,„(6„>>„gAƒ˙ƒ˙V0ILK "‚ ?‚-‚‚" Dƒ˙qcAUX 8 „‡kAEƒ˙ƒ˙.CON <‚| ƒ˙#ƒ˙ƒ˙AUX /c„wB?{zƒ˙ƒ˙ƒ˙NOS AUX b}…iˆ{Mƒ˙ƒ˙+AUX _$‚io1ƒ˙ƒ˙QWƒ˙AUX sŒa‡60ƒ˙ƒ˙?ILK #G^„0‰5„3‰„U‰„m‰Fƒ˙t+CLD 7„z†ƒ˙7FLW !:6&„z†„z‡ƒ˙ƒ˙8 6$AUX <.… †L73ƒ˙ƒ˙-ILK #o'…‡…†{…†j…†Zƒ˙ƒ˙$8CLD Z7†=‡;ƒ˙FLW "~%…‡†.‡ƒ˙ƒ˙< $:AUX V8 …a‡ ;Kƒ˙ƒ˙ƒ˙NOS AUX Ys„{ˆBƒ˙ƒ˙E]AUX ` €yŽ9Nƒ˙4ƒ˙NOS FLW '9;&ƒ~ˆ1ƒ~‡%„b‡%7ƒ˙.9$NOS AUX Pf0B#ƒ˙ƒ˙,ILK $eŽDkŽa‚Žn‚Žxƒ˙ƒ˙bcILK !M3„m‡„T‡p„?‡l„‡kWM>.NOS NOS NOS NOS RPT Kcˆ.„3Š#„vRPT J\ŒƒCŽ%„}ILK !TŠ0†?І,Š †+‰o†$Tƒ˙pyILK !^E… ˆ…&ˆ…;ˆ…Zˆ^ƒ˙>2ILK &|!ŒDYŒ=‚Œ‚/ŒDƒ˙ƒ˙-JCON ††<ƒ˙ƒ˙K?ƒ˙CLD [:€CˆUƒ˙[FLW !hZ&€RˆX‚ˆXƒ˙ƒ˙gZ ILK !jk_‰ F‰=‰8ˆxkƒ˙`gILK $QŒa†QŒa†8Œa†+Œa†ƒ˙_ILK #5M…0ˆJ…>ˆ%…:ˆ&…\ˆ ƒ˙ƒ˙}2ILK #sŽ2‚|ŽƒlŽ„WŽdƒ˙DbAUX  `n‰'#ƒ˙d\ƒ˙ƒ˙FLW ! h&€G†:q†:ƒ˙ƒ˙ih"LEV q2bŽ7_ƒ˙ƒ˙ƒ˙ƒ˙AUX 0q‚,Ž}+ƒ˙-ƒ˙ƒ˙/ILK %0j&‰K1‰8C‰*^‰(ƒ˙ƒ˙/`CON  ‚‡&ƒ˙ƒ˙lƒ˙ƒ˙CON  Y€\‰$ƒ˙jƒ˙ƒ˙AUX m3ˆi%[\ƒ˙ƒ˙ƒ˙CLD a[8†7ƒ˙aAUX `†K"anƒ˙ƒ˙ƒ˙ILK #d\€c‰ €rˆz ˆt#ˆmƒ˙ƒ˙fgILK "\F‚ˆ]sˆe_ˆnCˆkjƒ˙ gILK $!n‚‡V‡A†s'†Wƒ˙ƒ˙eiAUX @g‹I‚QŞ$ƒ˙7ƒ˙ILK !lV€H†}€[†\€s†R †Noƒ˙XiILK ")9q†=U†AH†K,†Klƒ˙"iCON yuŠ8†G4ƒ˙L&IAUX cbL*ƒ˙-ILK !V)€fƒM€pƒ1€}ƒ)ƒ)ƒ˙CON >4M†9,ƒ˙ ƒ˙VAUX W]„/‰E;,ƒ˙5Cƒ˙CON p8ˆ{†D9ƒ˙T8HILK %Tˆ7†ˆt†‰ …u‰S†ƒ˙ƒ˙yLEV Y[‰‰;ƒ˙xƒ˙ƒ˙ ƒ˙ILK %E‰"‰A‰?‰L‰M‰S‰j‰]\ƒ˙wYAUX Ip‰`† >Lƒ˙ƒ˙ƒ˙ILK "W,„fŽ„j„p„t2,ƒ˙0FLW )~9%…zˆ5…z‡O…‡O…‡-Aƒ˙2~$ILK $MN(Œ{[ŒqyŒp‚(ŒYNƒ˙.JAUX 2W…*ˆY6{:^ƒ˙_CLD ;{…wˆ@ƒ˙{RPT 4O ˛sƒ’>AUX +?ˆ'†<ƒ˙v?AUX `_Œa†*ƒ˙ƒ˙qRPT ' ށ’xƒ”CAUX CˆgƒI*ƒ˙ƒ˙ƒ˙RPT B ’‡WŽdŠ"*RPT K'–‚—[ILK _]Œa†qŒa‡Œa‡Œa‡& ]_4RPT O ‚ţ,‹‚n‹3ILK %vˆ(‹=ˆU‹%‰‹‰)‹3ƒ˙ƒ˙ CON &@„(Tƒ˙Vƒ˙ƒ˙AUX . ‰5‹==ƒ˙ƒ˙ƒ˙AUX ?f‹k†9ƒ˙ƒ˙0C1CLD  aˆ‚ƒ˙ FLW $ &ˆ.‚ ‰1‚ ƒ˙ƒ˙ &AUX ,ˆo‚1. ƒ˙ƒ˙ƒ˙CLD  ‹‚ƒ˙FLW $&‰c‚Št‚ƒ˙ƒ˙&AUX ,1Š+‚//ƒ˙ƒ˙ƒ˙AUX Hˆ ‚zBƒ˙]ƒ˙FLW "=&‰K‚2‰Kƒ)ƒ˙&#AUX g#‰\‚m0ƒ˙ƒ˙ƒ˙AUX -Š/ƒ9Bƒ˙]ILK $-Uˆhƒ9ˆkƒ ˆx‚pˆq‚Aƒ˙ILK &xˆ*‚nˆ=‚WˆJ‚Kˆb‚:ƒ˙ƒ˙AUX  ˆ‹E<ƒ˙?ILK %#_‹ƒŠg‚pŠ_‚^Š7‚:ƒ˙1ILK %NŠ1ƒ)Š5ƒŠ6‚hŠ.‚?Eƒ˙ILK # ‹x†/Œ†Œ*† ŒQ†]ƒ˙ ILK $DS‰c‚0‰q‚:‰i‚L‰b‚^ƒ˙ƒ˙&CON ]YŠ*‰ ƒ˙Zƒ˙ƒ˙AUX 4/ƒa†P<ƒ˙ƒ˙L?YCON C ˆ6ˆ2ƒ˙%ƒ˙ƒ˙CON /„#†,3ƒ˙!ƒ˙ƒ˙ILK %Ll„.†1„R†D„]†V„s‡ƒ˙ƒ˙ $ILK %%ˆjˆfˆˆ`‰ ˆ^‰ˆXƒ˙ƒ˙%(ILK "U‚q‚D&‚'%v-Qƒ˙/CILK &XU‰m‰W‰B‰0‰5‰!‰/ˆc%ƒ˙Y(ILK &"\ˆEˆˆlˆ!‰ˆ0‰!ˆI*ƒ˙(CON &I†\†P4ƒ˙)ƒ˙pRPT ͅ‹q‡ƒ˙ƒ˙ƒ˙ILK #EL…I†…P†-…7†;…†F9ƒ˙H8RPT  śƒjn…i’9ILK '*DŠ ˆ Š&ˆ#Š>ˆ+Š_ˆ5ƒ˙ƒ˙?CCON [(‰‡38ƒ˙Dƒ˙ƒ˙ILK %E‹:‚K‹ ‚9Šn‚(Š;‚-ƒ˙ƒ˙mCON u+…‰i9ƒ˙ƒ˙Gƒ˙uCLD {Aƒ{ˆ<ƒ˙AILK "A…‰ …ˆw…ˆt… ˆeƒ˙+}FLW #A>&‰H‚ ‰Hƒ˙@&<LEV /O‰H€{:ƒ˙ƒ˙;ƒ˙ƒ˙ƒ˙CLD >‰*‡kƒ˙>FLW ';=&‰9‡nŠF‡nƒ˙ƒ˙? =2AUX ‰‡<>A5ƒ˙AUX Hm‰YJ;ƒ˙E.ƒ˙ILK &D:‰<ˆN‰[ˆD‰fˆ"‰vˆ Dƒ˙(?RPT N LaK’,AUX 2Šnˆ9;ƒ˙Uƒ˙ƒ˙tILK '5A‰‡6‰;‡>‰[‡J‰v‡rƒ˙ƒ˙6?ILK %x7‰cV‰|sŠ ‚Š"‚"7ƒ˙@ILK $kG…G‰C…/‰D…‰6…‰#Gƒ˙I+ILK %F5„z‰_„l‰K„j‰9„t‰&ƒ˙ƒ˙8+CON @…F†9ƒ˙ƒ˙38ƒ˙CON &y…W‰C4ƒ˙F&ƒ˙AUX 1+‚6ŒR7Mƒ˙ƒ˙`ILK #,M †††8†;††d…m‡)ƒ˙Y<ILK %3!ƒq†R„$†X„B†e„g‡!ƒ˙$ILK $K|1O‚ ‚.Œ`|ƒ˙+JRPT BP ˙ƒ>’s…=”>RPT ‚ ž\€PzRPT NQ ů„• …y•LRPT PR î‹’e”0RPT Q^ 䋐`’+RPT T Ŕ€K˜‚J™eRPT ^S هRgŠ’-ILK &$Z‹‰.‹‰‹ˆgŠwˆF5ƒ˙]CCON <ƒs),ƒ˙,sƒ˙ILK #Qz„HˆJ„5ˆ„6ˆ„‡xƒ˙ƒ˙W.ILK %\$Š ‰aŠD‰_Š\‰YЉFZ$Y]AUX w‰y‰b@xXƒ˙ƒ˙ILK &U*Š7‰Š[‰ Ši‰‹‰2ƒ˙*]CON w6ˆK‰|Aƒ˙\ƒ˙ƒ˙ILK '%XˆV‰w‰‰`‰-‰a‰i‰bƒ˙ƒ˙[YAUX t‹ ‰>BXUƒ˙>RPT RT އD’n‰C”9AUX 3Œa†a6ƒ˙}ƒ˙AUX i?‚'…j7ƒ˙ƒ˙Jƒ˙FORMćWSWLRES €`€`WMX FORMÄWLE SCI WPL1 †yƒiFORMœDGWDVWT SHC1 EQV SHG AUR WCL ZOM1 Y@SCR u0STY ICO CAP